Position in VTRS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$613,968
+$68,286 QoQ
Shares Held
38,663
-4.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#377
of 1,016 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BRIGHTON JONES LLC holds $5,900,788 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
12,830 | $2,162,368 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,916 | $1,579,976 | |
| 3 | VTRS |
Viatris Inc
This page
|
38,663 | $613,968 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
10,926 | $395,521 | |
| 5 | ZTS |
Zoetis Inc.
|
3,790 | $272,349 | |
| 6 | HLN |
Haleon plc
|
24,732 | $230,749 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
12,250 | $196,367 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
16,926 | $169,260 |
All Filings in VTRS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $613,968 | 38,663 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $545,682 | 40,391 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $342,124 | 34,558 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $227,822 | 25,512 | Shares | Sole | 2025-07-31 | |
| 2024-12-31 | $130,600 | 10,490 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $131,320 | 11,311 | Shares | Sole | 2025-03-04 | |
| No filing history on record for this holder in this stock. | ||||||